Departamento de Biologia, Universidade de Aveiro, Campus de Santiago, 3810-193, Aveiro, Portugal; Centro de Estudos do Ambiente e do Mar (CESAM), Universidade de Aveiro, Campus de Santiago, 3810-193, Aveiro, Portugal.
Centro Interdisciplinar de Investigação Marinha e Ambiental (CIIMAR/CIMAR), Terminal de Cruzeiros do Porto de Leixões, Avenida General Norton de Matos S/N, 4550-208, Matosinhos, Portugal; Faculdade de Ciências da Saúde, Universidade Fernando Pessoa (UFP), Rua Carlos da Maia 296, 4200-150, Porto, Portugal.
Environ Toxicol Pharmacol. 2021 Jan;81:103522. doi: 10.1016/j.etap.2020.103522. Epub 2020 Nov 2.
Due to their wide use, pharmaceuticals can be discarded, metabolized and excreted into the environment, potentially affecting aquatic organisms. Lipid-regulating drugs are among the most prescribed medications around the world, to control human cholesterol levels, in more than 20 million patients. Despite this massive use of lipid-regulating drugs, particularly simvastatin, the role of these drugs is not fully characterized and understood in terms of its potential toxicological effects at the environmental level. This work intended to characterize the toxicity of an acute (120 h post-fertilization) and chronic (60 days) exposure to the antihyperlipidemic drug simvastatin (in concentrations of 92.45, 184.9, 369.8, 739.6 and 1479.2 ng L), in the freshwater species zebrafish (Danio rerio). The concentrations hereby mentioned were implemented in both exposures, and were based on levels found in wastewater treatment plant influents (11.7 ± 3.2 μg L), effluents (2.65 ± 0.8 μg L) and Apies River (1.585 ± 0.3 μg L), located in Pretoria, South Africa and, particularly in the maximum levels found in effluents from wastewater treatment plants in Portugal (369.8 ng L). The acute effects were analysed focusing on behavioural endpoints (erratic and purposeful swimming), total distance travelled and swimming time), biomarkers of oxidative stress (the activities of the enzymes superoxide dismutase, catalase, glutathione peroxidase), biotransformation (the activity of glutathione S-transferases) and lipid peroxidation (levels of thiobarbituric acid reactive substances). Animals chronically exposed were also histologically analysed for sex determination and gonadal developmental stages identification. In terms of acute exposure, significant alterations were reported in terms of behavioural alterations (hyperactivity), followed by a general reduction in all tested biomarkers. Also, the analysis of chronically exposed fish evidenced no alterations in sex ratio and maturation stages. In addition, the analysis of chronically exposed fish evidenced no alterations in terms of sexual characteristics, suggesting that the chronic exposure of Danio rerio to simvastatin does not alter the sex ratio and maturation stages of individuals. This assumption suggests that simvastatin did not act as an endocrine disruptor. Moreover, the metabolism, neuronal interactions and the antioxidant properties of SIM seem to have modulated the hereby-mentioned results of toxicity. Results from this assay allow inferring that simvastatin can have an ecologically relevant impact in living organisms.
由于其广泛的应用,药品可能会被丢弃、代谢和排泄到环境中,从而潜在地影响水生生物。调节血脂的药物是全球范围内使用最广泛的药物之一,用于控制超过 2000 万患者的人类胆固醇水平。尽管大量使用调节血脂的药物,特别是辛伐他汀,但就其在环境水平上的潜在毒理学效应而言,这些药物的作用尚未得到充分的描述和理解。本工作旨在描述急性(受精后 120 小时)和慢性(60 天)暴露于降脂药辛伐他汀(浓度为 92.45、184.9、369.8、739.6 和 1479.2ng/L)对淡水物种斑马鱼(Danio rerio)的毒性。在这两种暴露中都实施了上述浓度,并基于污水处理厂进水(11.7±3.2μg/L)、出水(2.65±0.8μg/L)和比勒陀利亚 Apies 河(1.585±0.3μg/L)中发现的水平,特别是在南非比勒陀利亚污水处理厂出水的最高水平(369.8ng/L)。急性影响分析集中在行为终点(不规则和有目的的游泳)、总距离和游泳时间)、氧化应激生物标志物(超氧化物歧化酶、过氧化氢酶、谷胱甘肽过氧化物酶的活性)、生物转化(谷胱甘肽 S-转移酶的活性)和脂质过氧化(硫代巴比妥酸反应物质水平)。还对慢性暴露的动物进行了组织学分析,以确定性别和性腺发育阶段。在急性暴露方面,行为改变(过度活跃)方面报告了显著变化,随后所有测试的生物标志物普遍减少。此外,对慢性暴露鱼类的分析表明,性别比例和成熟阶段没有变化。此外,对慢性暴露鱼类的分析表明,在性特征方面没有变化,这表明 Danio rerio 慢性暴露于辛伐他汀不会改变个体的性别比例和成熟阶段。这一假设表明,辛伐他汀没有作为内分泌干扰物发挥作用。此外,SIM 的代谢、神经元相互作用和抗氧化特性似乎调节了上述毒性结果。该实验的结果表明,辛伐他汀可能对生物体产生具有生态意义的影响。